Machine learning is frequently being leveraged to tackle problems in the health sector including utilization for clinical decision-support. Its use has historically been focused on single modal data. Attempts to improve prediction and mimic the multimodal nature of clinical expert decision-making has been met in the biomedical field of machine learning by fusing disparate data. This review was conducted to summarize the current studies in this field and identify topics ripe for future research. We conducted this review in accordance with the PRISMA extension for Scoping Reviews to characterize multi-modal data fusion in health. Search strings were established and used in databases: PubMed, Google Scholar, and IEEEXplore from 2011 to 2021. A final set of 128 articles were included in the analysis. The most common health areas utilizing multi-modal methods were neurology and oncology. Early fusion was the most common data merging strategy. Notably, there was an improvement in predictive performance when using data fusion. Lacking from the papers were clear clinical deployment strategies, FDA-approval, and analysis of how using multimodal approaches from diverse sub-populations may improve biases and healthcare disparities. These findings provide a summary on multimodal data fusion as applied to health diagnosis/prognosis problems. Few papers compared the outputs of a multimodal approach with a unimodal prediction. However, those that did achieved an average increase of 6.4% in predictive accuracy. Multi-modal machine learning, while more robust in its estimations over unimodal methods, has drawbacks in its scalability and the time-consuming nature of information concatenation.

Artificial intelligence (AI) has revolutionized sectors all over the world, and it has the potential to improve healthcare as well. Consider how AI could enhance clinical outcomes and diagnoses by analyzing data from clinic visits, medications prescribed, laboratory tests performed, and procedures performed, along with data from outside the healthcare system, such as social networks, credit card transactions, census records, and web search activity logs that contain important health information. If you are looking for AI in healthcare books, this article is just for you. Check out our top AI in healthcare books down below. Traditional analytics and medical decision-making tools provide a lot of benefits that AI does not.

The University of South Australia will lead a world-first study, using artificial intelligence, to map the risks of the most fatal reproductive cancer in women worldwide so it can be detected and treated earlier. Internationally-renowned nutritional epidemiologist Professor Elina Hypponen and a team from UniSA's Australian Centre for Precision Health have been awarded $1.2 million by the Federal Government to map the genetic and physical risks of ovarian cancer, based on the health records of 273,000 women from the UK Biobank database. A machine learning model, which automatically analyses the data to identify patterns of risk, is expected to accurately predict which women will develop ovarian cancer in the next 15 years. Ovarian cancer is usually diagnosed very late due to vague symptoms and few known causes, with a five-year survival rate of less than 30 per cent for women with late-stage cancer. Genes, diet and lifestyle come into play and the researchers say a computational approach will narrow down those most at risk.

The successful candidate is expected to join an established bioinformatics team. The ongoing projects in BSML focus on precision medicine, functional roles of genetic variants in complex disease, next-generation sequencing and single cell RNA sequencing method development and data analyses, deep learning, and regulatory networks. Integrative genomics and deep learning approaches are often applied. Funding (NIH grants, CPRIT, and lab/center startup) is available to support this position for 3 years and promotion to faculty positions is possible. The candidate will have the opportunity to access many high throughput datasets and interact with investigators across UTHealth and Texas Medical Center.

People over 50 are the fastest growing demographic group worldwide. This creates both opportunities and challenges for the global economy and healthcare systems. The Longevity Industry, which provides products and services for those aged over 50 is becoming a multi-trillion-dollar industry. There are currently 260 companies, 250 investors, 10 non-profits, and 10 research labs in the Longevity Industry in the UK alone. In the next decade, Longevity policies enacted by governments, and changes in the financial industry will transform society.

People over 50 are the fastest growing demographic group worldwide. This creates both opportunities and challenges for the global economy and healthcare systems. The Longevity Industry, which provides products and services for those aged over 50 is becoming a multi-trillion-dollar industry. There are currently 260 companies, 250 investors, 10 non-profits, and 10 research labs in the Longevity Industry in the UK alone. In the next decade, Longevity policies enacted by governments, and changes in the financial industry will transform society.

Often, the phrase "digital health" conjures images of smart watches or apps that process your health data to give a readout of a parameter like heart rate. That is part of digital health, to be sure, but at the Big Data in Precision Health conference last week, four speakers during the last session of the conference offered a much more expansive vision for digital health technologies. They discussed robotics, precision mental health and personal behaviors in health practices -- the ever-elusive key to actually making changes in your own health. "Despite the mass amounts of data that we have today, we've still yet to understand how to change [health] behavior," said Jennifer Schneider, MD, the chief medical officer at Livongo, a company that develops products tailored to individuals with chronic diseases, such as devices that monitor blood sugar and provide personalized reminders to people with diabetes. But in areas such as mental health, it's not always easy to know what actions to take, even if you are motivated.

Magnetoencephalography (MEG) is a functional neuroimaging modality that records the magnetic fields induced by neuronal activity. It provides better temporal resolution than fMRI and is less affected by noise from intervening tissues than EEG. We propose a data driven, fully automated approach that extracts statistically independent MEG components and a convolutional neural network to discriminate the artifactual components from neuronal ones, without tedious manual labeling. Our custom, 10-layer Convolutional Neural Network (CNN) directly labels eye-blink artifacts. The spatial features the CNN learns are visualized using attention mapping, to reveal what it has learned and bolster confidence in the method's ability to generalize to unseen data.

At the University of Michigan, Jenna Wiens, PhD, an assistant professor of computer science and engineering, draws on her computational expertise to break down enormous data sets using machine learning. Ultimately, she hopes to improve disease modeling and to predict patient outcomes. She will be speaking at the Big Data in Precision Health conference on May 24. I recently emailed with her to learn more about her perspective on the convergence of computation, big data and health. In your lab, Machine Learning for Data-Driven Decisions, how do you approach the integration of big data and health care?

Neural networks (NNs) and deep learning (DL) currently provide the best solutions to many problems in image recognition, speech recognition, natural language processing, control and precision health. NN and DL make the artificial intelligence (AI) much closer to human thinking modes. However, there are many open problems related to DL in NN, e.g.: convergence, learning efficiency, optimality, multi-dimensional learning, on-line adaptation. This requires to create new algorithms and analysis methods. Practical applications both require and stimulate this development.